Sympathovagal equilibrium analysis in patients with COVID-19

Abstract Introduction: With the increase of COVID-19 cases, an unusual manifestation for this type of virus began to appear anosmia and dysgeusia, which could indicate a neurologic alteration. In this context, it seems likely that subclinical manifestations of baroreflex involvement occur. The vegetative nervous system carries out the regulation of the baroreflex through the balance between sympathetic and parasympathetic activity. The objective of this study is to verify whether patients with COVID-19 present alteration of this equilibrium. Material and methods: Patients included had a confirmed diagnosis of COVID-19 admitted to the Internal Medicine Department of JB Iturraspe Hospital. A Holter recording was performed at rest for 5 minutes, determining the variables in the frequency domain using Fourier transform analysis. We excluded patients with diabetes, medicated with drugs that modify heart rate or with a history of irradiation to the neck. Results: 68 patients were studied. The mean age was 49±13 years. The median systolic blood pressure was 120 mmHg and the diastolic blood pressure 80 mmHg. The heart rate was 76±13 beats per minute and the median respiratory rate was 24 (16 to 40). Anosmia was observed in 22% and dysgeusia in 19% The variables in the frequency domain were: Low-frequency power (LF) 135.8ms2 (13.7-2861.7); High-frequency power (HF), 89.04ms2 (4.1-5234.4), LFnu 57.5±22.3, HFnu 43.1±22.6. LF:HF 2.1±2. 41.2% of the patients had a high LF:HF. Conclusions: LF and HF components can be obtained through frequency analysis. The relationship between these two elements would thus represent the sympathovagal balance and is expressed as the LF/HF ratio. We observed that 41.2% of the studied patients showed elevated LF/HF ratio. The 41.2% of the patients presented an increased LF:HF ratio, which could be interpreted as an alteration in autonomic function.

Saved in:
Bibliographic Details
Main Authors: Musacchio,Héctor M, Cogliano,Florencia, Miño,Hugo JD, Romagnoli,Gonzalo, Debona,Florencia, Godano,Delfina, Barbone,Federico
Format: Digital revista
Language:English
Published: Hospital San Pedro 2022
Online Access:https://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S2695-50752022000200004
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:scielo:S2695-50752022000200004
record_format ojs
spelling oai:scielo:S2695-507520220002000042023-11-27Sympathovagal equilibrium analysis in patients with COVID-19Musacchio,Héctor MCogliano,FlorenciaMiño,Hugo JDRomagnoli,GonzaloDebona,FlorenciaGodano,DelfinaBarbone,Federico Dysautonomia COVID-19 Heart rate variability Abstract Introduction: With the increase of COVID-19 cases, an unusual manifestation for this type of virus began to appear anosmia and dysgeusia, which could indicate a neurologic alteration. In this context, it seems likely that subclinical manifestations of baroreflex involvement occur. The vegetative nervous system carries out the regulation of the baroreflex through the balance between sympathetic and parasympathetic activity. The objective of this study is to verify whether patients with COVID-19 present alteration of this equilibrium. Material and methods: Patients included had a confirmed diagnosis of COVID-19 admitted to the Internal Medicine Department of JB Iturraspe Hospital. A Holter recording was performed at rest for 5 minutes, determining the variables in the frequency domain using Fourier transform analysis. We excluded patients with diabetes, medicated with drugs that modify heart rate or with a history of irradiation to the neck. Results: 68 patients were studied. The mean age was 49±13 years. The median systolic blood pressure was 120 mmHg and the diastolic blood pressure 80 mmHg. The heart rate was 76±13 beats per minute and the median respiratory rate was 24 (16 to 40). Anosmia was observed in 22% and dysgeusia in 19% The variables in the frequency domain were: Low-frequency power (LF) 135.8ms2 (13.7-2861.7); High-frequency power (HF), 89.04ms2 (4.1-5234.4), LFnu 57.5±22.3, HFnu 43.1±22.6. LF:HF 2.1±2. 41.2% of the patients had a high LF:HF. Conclusions: LF and HF components can be obtained through frequency analysis. The relationship between these two elements would thus represent the sympathovagal balance and is expressed as the LF/HF ratio. We observed that 41.2% of the studied patients showed elevated LF/HF ratio. The 41.2% of the patients presented an increased LF:HF ratio, which could be interpreted as an alteration in autonomic function.Hospital San PedroIberoamerican Journal of Medicine v.4 n.2 20222022-01-01journal articletext/htmlhttps://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S2695-50752022000200004en
institution SCIELO
collection OJS
country España
countrycode ES
component Revista
access En linea
databasecode rev-scielo-es
tag revista
region Europa del Sur
libraryname SciELO
language English
format Digital
author Musacchio,Héctor M
Cogliano,Florencia
Miño,Hugo JD
Romagnoli,Gonzalo
Debona,Florencia
Godano,Delfina
Barbone,Federico
spellingShingle Musacchio,Héctor M
Cogliano,Florencia
Miño,Hugo JD
Romagnoli,Gonzalo
Debona,Florencia
Godano,Delfina
Barbone,Federico
Sympathovagal equilibrium analysis in patients with COVID-19
author_facet Musacchio,Héctor M
Cogliano,Florencia
Miño,Hugo JD
Romagnoli,Gonzalo
Debona,Florencia
Godano,Delfina
Barbone,Federico
author_sort Musacchio,Héctor M
title Sympathovagal equilibrium analysis in patients with COVID-19
title_short Sympathovagal equilibrium analysis in patients with COVID-19
title_full Sympathovagal equilibrium analysis in patients with COVID-19
title_fullStr Sympathovagal equilibrium analysis in patients with COVID-19
title_full_unstemmed Sympathovagal equilibrium analysis in patients with COVID-19
title_sort sympathovagal equilibrium analysis in patients with covid-19
description Abstract Introduction: With the increase of COVID-19 cases, an unusual manifestation for this type of virus began to appear anosmia and dysgeusia, which could indicate a neurologic alteration. In this context, it seems likely that subclinical manifestations of baroreflex involvement occur. The vegetative nervous system carries out the regulation of the baroreflex through the balance between sympathetic and parasympathetic activity. The objective of this study is to verify whether patients with COVID-19 present alteration of this equilibrium. Material and methods: Patients included had a confirmed diagnosis of COVID-19 admitted to the Internal Medicine Department of JB Iturraspe Hospital. A Holter recording was performed at rest for 5 minutes, determining the variables in the frequency domain using Fourier transform analysis. We excluded patients with diabetes, medicated with drugs that modify heart rate or with a history of irradiation to the neck. Results: 68 patients were studied. The mean age was 49±13 years. The median systolic blood pressure was 120 mmHg and the diastolic blood pressure 80 mmHg. The heart rate was 76±13 beats per minute and the median respiratory rate was 24 (16 to 40). Anosmia was observed in 22% and dysgeusia in 19% The variables in the frequency domain were: Low-frequency power (LF) 135.8ms2 (13.7-2861.7); High-frequency power (HF), 89.04ms2 (4.1-5234.4), LFnu 57.5±22.3, HFnu 43.1±22.6. LF:HF 2.1±2. 41.2% of the patients had a high LF:HF. Conclusions: LF and HF components can be obtained through frequency analysis. The relationship between these two elements would thus represent the sympathovagal balance and is expressed as the LF/HF ratio. We observed that 41.2% of the studied patients showed elevated LF/HF ratio. The 41.2% of the patients presented an increased LF:HF ratio, which could be interpreted as an alteration in autonomic function.
publisher Hospital San Pedro
publishDate 2022
url https://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S2695-50752022000200004
work_keys_str_mv AT musacchiohectorm sympathovagalequilibriumanalysisinpatientswithcovid19
AT coglianoflorencia sympathovagalequilibriumanalysisinpatientswithcovid19
AT minohugojd sympathovagalequilibriumanalysisinpatientswithcovid19
AT romagnoligonzalo sympathovagalequilibriumanalysisinpatientswithcovid19
AT debonaflorencia sympathovagalequilibriumanalysisinpatientswithcovid19
AT godanodelfina sympathovagalequilibriumanalysisinpatientswithcovid19
AT barbonefederico sympathovagalequilibriumanalysisinpatientswithcovid19
_version_ 1787236486522863616